<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0002977"><a href="http://purl.obolibrary.org/obo/MONDO_0002977">MONDO:0002977</a></h3>
<p><strong>Label:</strong> autoimmune disease of the nervous system</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0018305">MONDO:0018305</a> (chronic granulomatous disease), <a href="http://purl.obolibrary.org/obo/MONDO_0018105">MONDO:0018105</a> (Wolfram syndrome), <a href="http://purl.obolibrary.org/obo/MONDO_0005301">MONDO:0005301</a> (multiple sclerosis), <a href="http://purl.obolibrary.org/obo/MONDO_0019432">MONDO:0019432</a> (rheumatoid factor-negative juvenile idiopathic arthritis), <a href="http://purl.obolibrary.org/obo/MONDO_0019433">MONDO:0019433</a> (Oligoarticular juvenile idiopathic arthritis), <a href="http://purl.obolibrary.org/obo/MONDO_0009688">MONDO:0009688</a> (myasthenia gravis), <a href="http://purl.obolibrary.org/obo/MONDO_0007691">MONDO:0007691</a> (Guillain-Barre syndrome),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://purl.obolibrary.org/obo/OMIM_159400">OMIM:159400</a>, <a href="http://purl.obolibrary.org/obo/OMIM_222300">OMIM:222300</a>, <a href="http://purl.obolibrary.org/obo/OMIM_306400">OMIM:306400</a>, <a href="http://www.orpha.net/ORDO/Orphanet_85408">Orphanet:85408</a>, <a href="http://purl.obolibrary.org/obo/OMIM_604928">OMIM:604928</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612594">OMIM:612594</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613960">OMIM:613960</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612596">OMIM:612596</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612595">OMIM:612595</a>, <a href="http://purl.obolibrary.org/obo/OMIM_614810">OMIM:614810</a>, <a href="http://purl.obolibrary.org/obo/OMIM_139393">OMIM:139393</a>, <a href="http://www.orpha.net/ORDO/Orphanet_98916">Orphanet:98916</a>, <a href="http://purl.obolibrary.org/obo/OMIM_233700">OMIM:233700</a>, <a href="http://purl.obolibrary.org/obo/OMIM_598500">OMIM:598500</a>, <a href="http://www.orpha.net/ORDO/Orphanet_379">Orphanet:379</a>, <a href="http://purl.obolibrary.org/obo/OMIM_126200">OMIM:126200</a>, <a href="http://purl.obolibrary.org/obo/OMIM_254200">OMIM:254200</a>, <a href="http://purl.obolibrary.org/obo/OMIM_138990">OMIM:138990</a>, <a href="http://www.orpha.net/ORDO/Orphanet_85410">Orphanet:85410</a>, <a href="http://www.orpha.net/ORDO/Orphanet_2932">Orphanet:2932</a>, <a href="http://purl.obolibrary.org/obo/OMIM_233710">OMIM:233710</a>, <a href="http://purl.obolibrary.org/obo/OMIM_233690">OMIM:233690</a>, <a href="http://www.orpha.net/ORDO/Orphanet_3463">Orphanet:3463</a>, <a href="http://purl.obolibrary.org/obo/OMIM_607085">OMIM:607085</a>, <a href="http://purl.obolibrary.org/obo/OMIM_233670">OMIM:233670</a>, <a href="http://www.orpha.net/ORDO/Orphanet_589">Orphanet:589</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0000118">HP:0000118</a> (Phenotypic abnormality) 42.15%</li>
<li>Thing 42.13%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000001">HP:0000001</a> (All) 42.13%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001874">HP:0001874</a> (Abnormality of neutrophils) and (not (<a href="http://purl.obolibrary.org/obo/HP_0004332">HP:0004332</a> (Abnormality of lymphocytes))) 36.85%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001874">HP:0001874</a> (Abnormality of neutrophils) and (not (<a href="http://purl.obolibrary.org/obo/HP_0001507">HP:0001507</a> (Growth abnormality))) 36.85%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002715">HP:0002715</a> (Abnormality of the immune system) 35.93%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001874">HP:0001874</a> (Abnormality of neutrophils) and (not (<a href="http://purl.obolibrary.org/obo/HP_0010701">HP:0010701</a> (Abnormal immunoglobulin level))) 34.92%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010978">HP:0010978</a> (Abnormality of immune system physiology) 32.65%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001939">HP:0001939</a> (Abnormality of metabolism/homeostasis) 28.25%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001871">HP:0001871</a> (Abnormality of blood and blood-forming tissues) 27.98%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000924">HP:0000924</a> (Abnormality of the skeletal system) 27.37%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010987">HP:0010987</a> (Abnormality of cellular immune system) 24.88%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000707">HP:0000707</a> (Abnormality of the nervous system) 24.84%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0025031">HP:0025031</a> (Abnormality of the digestive system) 23.93%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000478">HP:0000478</a> (Abnormality of the eye) 21.33%</li>
</ul>
</body>
</html>
